In an adipocyte-conditioned-medium model, exposure of adipocytes to 100 μM acipimox for 6 h reduced the subsequent protective effect of their medium on lapatinib-treated BT-474 cells. This indirect assay does not establish acipimox monotherapy activity against breast cancer cells. [3]
HCAR2-linked cAMP response
Cell-based study · HEK293 cells transiently expressing wild-type human HCAR2 [1]
Acipimox reduced forskolin-stimulated cAMP in the wild-type HCAR2 concentration-response experiment.
Literature-Reported Treatment Conditions
- Exposure duration
- 30 min agonist stimulation at 37 °C
- Method
- Cellular concentration-response assay
- Co-treatment
- 20 μM forskolin and 500 μM IBMX during agonist stimulation
- Reported limits
- Exact tested concentration series and acipimox vehicle are not stated in the main cAMP assay methods. Triplicate is not identified as biological versus technical replication.
Methods and source locations
Compound reported in the paper: Acipimox; Compound label in the paper: Acipimox
Receptor-expressing cell assay; no recommended concentration, clinical effect or absolute receptor selectivity inferred.
Results: Ligand recognition of HCAR2; Figure 2a,i and caption; Materials and methods: cAMP assay
Forskolin-stimulated intracellular cAMP: Gi/o cAMP fluorescence assay — Results: Ligand recognition of HCAR2; Figure 2a,i and caption; Materials and methods: cAMP assay
Inhibition of recombinant human carbonic anhydrases
Biochemical assay · Recombinant human carbonic anhydrase isoforms I, II, III, IV, VA, VB, VI, VII, IX, XII, XIII and XIV [2]
Acipimox inhibited CO2 hydration by the tested human carbonic anhydrases, with weaker inhibition of hCA XIII.
Literature-Reported Treatment Conditions
- Exposure duration
- 15 min enzyme–inhibitor preincubation; initial rates followed for 10–100 s
- Method
- Stopped-flow assay; 10 mM HEPES, pH 7.4; CO2 substrate 1.7–17 mM
- Vehicle
- Stock solutions in distilled-deionized water with maximum 5% DMSO; subsequent assay-buffer dilutions
- Reported limits
- Final DMSO percentage and full inhibitor concentration series are not explicitly reported. Ki values are measurements, not treatment recommendations.
Methods and source locations
Compound reported in the paper: Acipimox; Compound label in the paper: Acipimox
Cell-free inhibition only; no cellular target engagement or antiobesity efficacy inferred.
Sections 2.2 Carbonic anhydrase inhibition, 2.3 Chemicals, 3.1 CA inhibition; Table 1, compound 1 column and footnote
CO2 hydration by human carbonic anhydrases: Stopped-flow CO2 hydration assay; uncatalyzed rates subtracted; nonlinear least squares and Cheng–Prusoff analysis — Sections 2.2 Carbonic anhydrase inhibition, 2.3 Chemicals, 3.1 CA inhibition; Table 1, compound 1 column and footnote
Replicate and uncertainty description: Table footnote does not define the error as SD or SEM — Table 1 footnote
Adipocyte-conditioned medium and lapatinib response
Cell-based study · Differentiated murine 3T3-F442A adipocytes (#3T3) and human BT-474 breast cancer cells [3]
Conditioned medium from acipimox-exposed adipocytes produced a lower lapatinib IC50 in BT-474 cells than conditioned medium from untreated adipocytes.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM acipimox applied to adipocytes
- Exposure duration
- 6 h adipocyte conditioning; BT-474 cells subsequently exposed to lapatinib for 72 h
- Method
- Conditioned-medium transfer followed by MTT assay
- Co-treatment
- Lapatinib concentration-response in recipient BT-474 cells; acipimox applied during adipocyte conditioning
- Reported limits
- Acipimox vehicle, residual drug carryover and exact lapatinib concentration series are not specified for Figure 6B. No numeric IC50 or acipimox-specific significance is inferred from the bars.
Methods and source locations
Compound reported in the paper: Acipimox; Compound label in the paper: Acipimox
Indirect conditioned-medium assay; not evidence of acipimox monotherapy cytotoxicity, identified soluble mediators or in vivo anticancer efficacy.
Methods: Cell culture, Cytotoxicity MTT assay, Statistical analysis, Materials; Results Sec18; Figure 6B and caption
Lapatinib response after transfer of adipocyte-conditioned medium: MTT readout after lapatinib exposure; IC50 calculated using Compusyn — Methods: Cell culture, Cytotoxicity MTT assay, Statistical analysis, Materials; Results Sec18; Figure 6B and caption